Navigation Links
Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Date:8/19/2007

-- New Phase 3 trial of Genasense(R) seeks to confirm benefit in melanoma

-- New IND filed for clinical-stage product to treat bone disease -- Company regains compliance for NASDAQ Global Markets listing; Genta

common stock to resume trading under "GNTA" symbol in August 2007 -- Named-patient/compassionate-use program for Genasense will continue

during Phase 3 trial

-- Appeal of FDA decision on Genasense NDA in CLL pending

BERKELEY HEIGHTS, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTAD) today announced financial results and corporate highlights for the second quarter ended June 30, 2007.

"Over the past several months, we critically examined our development programs and have concluded that our assets and employees represent a significant value opportunity for shareholders," commented Dr. Raymond P. Warrell, Jr., Genta's Chairman and Chief Executive Officer. "Our lead compound, Genasense(R), has demonstrated improved outcomes for patients with CLL and melanoma, and we plan to pursue plans that will seek global regulatory approvals of this drug. In addition to developing dosing schedules of Genasense that may simplify its administration, we have added a new clinical- stage compound with the announcement of an IND filing for an orally available gallium product to treat accelerated bone loss. We plan to continue ongoing efforts to further diversify the Company's portfolio and leverage our expertise in clinical research."

New Randomized Phase 3 Trial of Genasense plus Dacarbazine in Advanced Melanoma

The Company has announced plans to initiate a new Phase 3 trial, now known as AGENDA: "A Randomized Controlled Trial
'/>"/>

SOURCE Genta Incorporated

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... -- Moms are ready to live the "measured life" ... kids, according to the results of the BabyCenter® U.S. ... for Moms, the latest installment in BabyCenter,s 21 st ... and parenting web and mobile destination worldwide, conducted the ... say they can,t think of a reason not to ...
(Date:10/22/2014)...  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today that James ... has been elected to the Company,s Board of Directors, ... Anderson , Executive Chairman of CryoLife, stated, "Since joining the ... excellent leader who is well positioned to maximize CryoLife,s ...
(Date:10/22/2014)... , Oct. 21, 2014  Early symptoms ... subtle or unnoticed, but new technology, coupled with ... and leading to earlier detection of eye diseases, ... 29 million Americans. If left untreated, these diseases ... blindness. Recently, optometric researchers have ...
Breaking Medicine Technology:BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
... Inc. (OTC Bulletin Board, OTCQB: MZEI) announces it ... recent developments in its variant of AsepticSure™ designed ... The application, filed under the Patent Co-operation Treaty, ... major industrialized countries for this government variant of ...
... Sept. 9 Live video detailing has made ... 2000s, according to pharmaceutical and healthcare market research company ... adoption of live video detailing has more than doubled in ... share of these users self-report that their prescribing behavior is ...
Cached Medicine Technology:Medizone International Files For Additional Bio-Terrorism Countermeasures Patent Protection 2New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting 2New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting 3
(Date:10/22/2014)... October 22, 2014 Hay House is pleased ... Addiction and Upgrade Your Life (Paperback; $10.82) written by the ... & Recovery. This book is meant to help readers ... life of recovery. , Recovery 2.0 is not the ... Recovery 2.0 is a guide for what comes next. ...
(Date:10/22/2014)... Your Body’s Way , In a world where a multi-billion-dollar ... can be difficult to choose the right weight loss method. ... it the healthy way? Set aside the fads and resist ... regularly, and choose foods with the most nutritional benefits. ... exercise more and eat less. Despite the number of advertisements ...
(Date:10/22/2014)... Steven Reinberg HealthDay Reporter ... who quickly add weight and length may be showing a ... In adults, certain genes have been linked to increased ... gains in fat and lean muscle, the researchers said. ... and taller. By ages 2 and 3, however, these genes ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... Allegheny General Hospital’s (AGH) Cardiovascular Institute is ... repair a damaged mitral valve as the heart continues ... by Abbott Vascular , is designed to treat ... in which the heart’s mitral valve leaflets fail to ... heart’s left ventricle into the left atrium. The heart ...
Breaking Medicine News(10 mins):Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3
... , JACKSONVILLE, Fla. , Feb. ... Football League have partnered to encourage fans of the AFC Champion ... in their teams as they prepare for Super Bowl XLIV.  From ... raise the most money and awareness for the Wounded Warrior Project ...
... increases the "reinforcing effects" that make people vulnerable to ... a research team from the University of Valencia (UV), ... changes persist into adulthood. "Although MDMA and cocaine ... studies have been done to analyse the short and ...
... The National Heart, Lung, and Blood Institute (NHLBI), part ... contracts totaling $23.6 million to begin preclinical testing of ... or those who develop heart failure. The four-year program ... Each year in the United States, nearly 1,800 ...
... ... of pharmacy services, has expanded its presence in the Michigan and Ohio long-term care ... Baltimore, ... Michigan and Ohio long-term care marketplace with the addition of two new customers for ...
... complications noted with staples than sutures, study finds , ... a cesarean delivery are less likely to suffer complications ... staples, says a U.S. study. , It included more ... or scheduled cesarean delivery and were interviewed two to ...
... ... in the Chicago area and makes a perfect one of a kind Valentines gift. ... Naperville, IL (PRWEB) February 4, ... the same - an opportunity for couples to spend wonderful time away from distractions while ...
Cached Medicine News:Health News:Wounded Warrior Project and Operation Touchdown 2010 Join Forces for Super Bowl XLIV 2Health News:Wounded Warrior Project and Operation Touchdown 2010 Join Forces for Super Bowl XLIV 3Health News:Cocaine or ecstasy consumption during adolescence increases risk of addiction 2Health News:NHLBI funds preclinical tests on devices for infants and children with congenital heart defects 2Health News:NHLBI funds preclinical tests on devices for infants and children with congenital heart defects 3Health News:Two Long-Term Care Organizations Select Remedi SeniorCare for Pharmacy Services 2Health News:Two Long-Term Care Organizations Select Remedi SeniorCare for Pharmacy Services 3Health News:The Love Convention Returns With "Something New" at Hotel Arista on Valentines Weekend 2Health News:The Love Convention Returns With "Something New" at Hotel Arista on Valentines Weekend 3
... The Seal-Away CS and Alliance ... designed for the introduction of ... coronary sinus from a superior ... Jude Medical's outstanding peel-away introducer ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
... design and ergonomic handle for easy ... Nitinol markers on the proximal and ... visibility. Corrugated ring design provides flexibility ... ring pattern minimizes stent shortening, provides ...
... comprise the world's broadest line of ... Their advanced catheter design and materials ... with a soft, atraumatic tip. Available ... Supreme and Response catheters provide outstanding ...
Medicine Products: